nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00565	0.00926	CcSEcCtD
Alprazolam—Laryngeal pain—Capecitabine—esophageal cancer	0.00559	0.00918	CcSEcCtD
Alprazolam—Dysarthria—Cisplatin—esophageal cancer	0.00547	0.00897	CcSEcCtD
Alprazolam—Body temperature increased—Carboplatin—esophageal cancer	0.00497	0.00816	CcSEcCtD
Alprazolam—Hyperaesthesia—Capecitabine—esophageal cancer	0.00486	0.00797	CcSEcCtD
Alprazolam—Memory impairment—Capecitabine—esophageal cancer	0.00486	0.00797	CcSEcCtD
Alprazolam—Rhinorrhoea—Capecitabine—esophageal cancer	0.00471	0.00772	CcSEcCtD
Alprazolam—Rigors—Capecitabine—esophageal cancer	0.00467	0.00766	CcSEcCtD
Alprazolam—Dysphonia—Capecitabine—esophageal cancer	0.00463	0.0076	CcSEcCtD
Alprazolam—Chest discomfort—Capecitabine—esophageal cancer	0.00431	0.00707	CcSEcCtD
Alprazolam—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.00425	0.00697	CcSEcCtD
Alprazolam—Nasal congestion—Cisplatin—esophageal cancer	0.00412	0.00676	CcSEcCtD
Alprazolam—Dysarthria—Capecitabine—esophageal cancer	0.00403	0.00661	CcSEcCtD
Alprazolam—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00403	0.00661	CcSEcCtD
Alprazolam—Amnesia—Cisplatin—esophageal cancer	0.004	0.00656	CcSEcCtD
Alprazolam—Coordination abnormal—Capecitabine—esophageal cancer	0.00388	0.00637	CcSEcCtD
Alprazolam—Stupor—Methotrexate—esophageal cancer	0.0038	0.00624	CcSEcCtD
Alprazolam—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00368	0.00604	CcSEcCtD
Alprazolam—Urinary incontinence—Capecitabine—esophageal cancer	0.00368	0.00604	CcSEcCtD
Alprazolam—Irritability—Cisplatin—esophageal cancer	0.00358	0.00588	CcSEcCtD
Alprazolam—Breast disorder—Cisplatin—esophageal cancer	0.00339	0.00557	CcSEcCtD
Alprazolam—Cramp muscle—Cisplatin—esophageal cancer	0.00338	0.00555	CcSEcCtD
Alprazolam—Nasopharyngitis—Cisplatin—esophageal cancer	0.00336	0.00551	CcSEcCtD
Alprazolam—Mental disability—Capecitabine—esophageal cancer	0.00331	0.00543	CcSEcCtD
Alprazolam—Ear pain—Capecitabine—esophageal cancer	0.00324	0.00532	CcSEcCtD
Alprazolam—Sleep disorder—Capecitabine—esophageal cancer	0.0032	0.00524	CcSEcCtD
Alprazolam—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00317	0.00519	CcSEcCtD
Alprazolam—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00316	0.00519	CcSEcCtD
Alprazolam—Sweating increased—Cisplatin—esophageal cancer	0.00316	0.00519	CcSEcCtD
Alprazolam—Abdominal discomfort—Cisplatin—esophageal cancer	0.00311	0.0051	CcSEcCtD
Alprazolam—Hepatic failure—Capecitabine—esophageal cancer	0.00308	0.00505	CcSEcCtD
Alprazolam—Dysarthria—Methotrexate—esophageal cancer	0.003	0.00492	CcSEcCtD
Alprazolam—Libido decreased—Capecitabine—esophageal cancer	0.00298	0.0049	CcSEcCtD
Alprazolam—Hot flush—Capecitabine—esophageal cancer	0.00296	0.00485	CcSEcCtD
Alprazolam—Amnesia—Capecitabine—esophageal cancer	0.00295	0.00483	CcSEcCtD
Alprazolam—Increased appetite—Capecitabine—esophageal cancer	0.00295	0.00483	CcSEcCtD
Alprazolam—Menopausal symptoms—Capecitabine—esophageal cancer	0.00293	0.00481	CcSEcCtD
Alprazolam—Thirst—Capecitabine—esophageal cancer	0.00291	0.00477	CcSEcCtD
Alprazolam—Lethargy—Capecitabine—esophageal cancer	0.00282	0.00463	CcSEcCtD
Alprazolam—Pain in extremity—Capecitabine—esophageal cancer	0.00277	0.00454	CcSEcCtD
Alprazolam—Diplopia—Capecitabine—esophageal cancer	0.00277	0.00454	CcSEcCtD
Alprazolam—Osteoarthritis—Capecitabine—esophageal cancer	0.00277	0.00454	CcSEcCtD
Alprazolam—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00275	0.0045	CcSEcCtD
Alprazolam—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00274	0.0045	CcSEcCtD
Alprazolam—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00274	0.00449	CcSEcCtD
Alprazolam—Irritability—Capecitabine—esophageal cancer	0.00264	0.00433	CcSEcCtD
Alprazolam—Urinary retention—Capecitabine—esophageal cancer	0.00263	0.00432	CcSEcCtD
Alprazolam—Mood swings—Capecitabine—esophageal cancer	0.00262	0.0043	CcSEcCtD
Alprazolam—Ataxia—Capecitabine—esophageal cancer	0.0026	0.00427	CcSEcCtD
Alprazolam—Urinary tract disorder—Cisplatin—esophageal cancer	0.00257	0.00421	CcSEcCtD
Alprazolam—Liver function test abnormal—Capecitabine—esophageal cancer	0.00256	0.00419	CcSEcCtD
Alprazolam—Connective tissue disorder—Cisplatin—esophageal cancer	0.00255	0.00419	CcSEcCtD
Alprazolam—Urethral disorder—Cisplatin—esophageal cancer	0.00255	0.00418	CcSEcCtD
Alprazolam—Gynaecomastia—Methotrexate—esophageal cancer	0.00254	0.00417	CcSEcCtD
Alprazolam—Breast disorder—Capecitabine—esophageal cancer	0.0025	0.0041	CcSEcCtD
Alprazolam—Nasopharyngitis—Capecitabine—esophageal cancer	0.00248	0.00406	CcSEcCtD
Alprazolam—Muscular weakness—Capecitabine—esophageal cancer	0.00244	0.004	CcSEcCtD
Alprazolam—Eye disorder—Cisplatin—esophageal cancer	0.00243	0.00398	CcSEcCtD
Alprazolam—Tinnitus—Cisplatin—esophageal cancer	0.00242	0.00397	CcSEcCtD
Alprazolam—Cardiac disorder—Cisplatin—esophageal cancer	0.00241	0.00395	CcSEcCtD
Alprazolam—Dysphagia—Capecitabine—esophageal cancer	0.00239	0.00392	CcSEcCtD
Alprazolam—Influenza—Capecitabine—esophageal cancer	0.00239	0.00392	CcSEcCtD
Alprazolam—Mediastinal disorder—Cisplatin—esophageal cancer	0.00234	0.00384	CcSEcCtD
Alprazolam—Sweating increased—Capecitabine—esophageal cancer	0.00233	0.00382	CcSEcCtD
Alprazolam—Abdominal discomfort—Capecitabine—esophageal cancer	0.00229	0.00376	CcSEcCtD
Alprazolam—Hepatic failure—Methotrexate—esophageal cancer	0.00229	0.00376	CcSEcCtD
Alprazolam—Malnutrition—Cisplatin—esophageal cancer	0.00226	0.00371	CcSEcCtD
Alprazolam—Dysuria—Capecitabine—esophageal cancer	0.00224	0.00367	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00222	0.00365	CcSEcCtD
Alprazolam—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00218	0.00358	CcSEcCtD
Alprazolam—Weight increased—Capecitabine—esophageal cancer	0.00218	0.00357	CcSEcCtD
Alprazolam—Muscle spasms—Cisplatin—esophageal cancer	0.00217	0.00357	CcSEcCtD
Alprazolam—Weight decreased—Capecitabine—esophageal cancer	0.00216	0.00355	CcSEcCtD
Alprazolam—Infestation NOS—Capecitabine—esophageal cancer	0.00213	0.0035	CcSEcCtD
Alprazolam—Infestation—Capecitabine—esophageal cancer	0.00213	0.0035	CcSEcCtD
Alprazolam—Vision blurred—Cisplatin—esophageal cancer	0.00213	0.0035	CcSEcCtD
Alprazolam—Depression—Capecitabine—esophageal cancer	0.00213	0.00349	CcSEcCtD
Alprazolam—Tremor—Cisplatin—esophageal cancer	0.00212	0.00347	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00211	0.00347	CcSEcCtD
Alprazolam—Lethargy—Methotrexate—esophageal cancer	0.0021	0.00345	CcSEcCtD
Alprazolam—Ill-defined disorder—Cisplatin—esophageal cancer	0.0021	0.00344	CcSEcCtD
Alprazolam—Jaundice—Capecitabine—esophageal cancer	0.00208	0.00341	CcSEcCtD
Alprazolam—Osteoarthritis—Methotrexate—esophageal cancer	0.00206	0.00338	CcSEcCtD
Alprazolam—Malaise—Cisplatin—esophageal cancer	0.00204	0.00334	CcSEcCtD
Alprazolam—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00202	0.00331	CcSEcCtD
Alprazolam—Epistaxis—Capecitabine—esophageal cancer	0.00201	0.0033	CcSEcCtD
Alprazolam—Irritability—Methotrexate—esophageal cancer	0.00197	0.00323	CcSEcCtD
Alprazolam—Convulsion—Cisplatin—esophageal cancer	0.00196	0.00321	CcSEcCtD
Alprazolam—Mood swings—Methotrexate—esophageal cancer	0.00195	0.0032	CcSEcCtD
Alprazolam—Ataxia—Methotrexate—esophageal cancer	0.00194	0.00318	CcSEcCtD
Alprazolam—Myalgia—Cisplatin—esophageal cancer	0.00193	0.00316	CcSEcCtD
Alprazolam—Anxiety—Cisplatin—esophageal cancer	0.00192	0.00315	CcSEcCtD
Alprazolam—Hepatitis—Capecitabine—esophageal cancer	0.00191	0.00314	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00191	0.00314	CcSEcCtD
Alprazolam—Hypoaesthesia—Capecitabine—esophageal cancer	0.00191	0.00312	CcSEcCtD
Alprazolam—Liver function test abnormal—Methotrexate—esophageal cancer	0.0019	0.00312	CcSEcCtD
Alprazolam—Discomfort—Cisplatin—esophageal cancer	0.0019	0.00312	CcSEcCtD
Alprazolam—Urinary tract disorder—Capecitabine—esophageal cancer	0.00189	0.0031	CcSEcCtD
Alprazolam—Oedema peripheral—Capecitabine—esophageal cancer	0.00189	0.00309	CcSEcCtD
Alprazolam—Connective tissue disorder—Capecitabine—esophageal cancer	0.00188	0.00309	CcSEcCtD
Alprazolam—Urethral disorder—Capecitabine—esophageal cancer	0.00188	0.00308	CcSEcCtD
Alprazolam—Breast disorder—Methotrexate—esophageal cancer	0.00186	0.00305	CcSEcCtD
Alprazolam—Oedema—Cisplatin—esophageal cancer	0.00185	0.00303	CcSEcCtD
Alprazolam—Infection—Cisplatin—esophageal cancer	0.00183	0.00301	CcSEcCtD
Alprazolam—Erythema multiforme—Capecitabine—esophageal cancer	0.00181	0.00297	CcSEcCtD
Alprazolam—Nervous system disorder—Cisplatin—esophageal cancer	0.00181	0.00297	CcSEcCtD
Alprazolam—Tachycardia—Cisplatin—esophageal cancer	0.0018	0.00295	CcSEcCtD
Alprazolam—Skin disorder—Cisplatin—esophageal cancer	0.00179	0.00294	CcSEcCtD
Alprazolam—Eye disorder—Capecitabine—esophageal cancer	0.00179	0.00294	CcSEcCtD
Alprazolam—Tinnitus—Capecitabine—esophageal cancer	0.00179	0.00293	CcSEcCtD
Alprazolam—Hyperhidrosis—Cisplatin—esophageal cancer	0.00178	0.00293	CcSEcCtD
Alprazolam—Cardiac disorder—Capecitabine—esophageal cancer	0.00178	0.00291	CcSEcCtD
Alprazolam—Anorexia—Cisplatin—esophageal cancer	0.00176	0.00289	CcSEcCtD
Alprazolam—Angiopathy—Capecitabine—esophageal cancer	0.00174	0.00285	CcSEcCtD
Alprazolam—Flunitrazepam—CYP2A6—esophageal cancer	0.00174	0.226	CrCbGaD
Alprazolam—Mediastinal disorder—Capecitabine—esophageal cancer	0.00173	0.00283	CcSEcCtD
Alprazolam—Hypotension—Cisplatin—esophageal cancer	0.00172	0.00283	CcSEcCtD
Alprazolam—Chills—Capecitabine—esophageal cancer	0.00172	0.00282	CcSEcCtD
Alprazolam—Abdominal discomfort—Methotrexate—esophageal cancer	0.00171	0.0028	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00168	0.00276	CcSEcCtD
Alprazolam—Mental disorder—Capecitabine—esophageal cancer	0.00168	0.00275	CcSEcCtD
Alprazolam—Malnutrition—Capecitabine—esophageal cancer	0.00167	0.00273	CcSEcCtD
Alprazolam—Dysuria—Methotrexate—esophageal cancer	0.00167	0.00273	CcSEcCtD
Alprazolam—Paraesthesia—Cisplatin—esophageal cancer	0.00166	0.00272	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00166	0.00271	CcSEcCtD
Alprazolam—Dyspnoea—Cisplatin—esophageal cancer	0.00165	0.0027	CcSEcCtD
Alprazolam—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00163	0.00267	CcSEcCtD
Alprazolam—Back pain—Capecitabine—esophageal cancer	0.00161	0.00264	CcSEcCtD
Alprazolam—Decreased appetite—Cisplatin—esophageal cancer	0.0016	0.00263	CcSEcCtD
Alprazolam—Muscle spasms—Capecitabine—esophageal cancer	0.0016	0.00263	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00159	0.00261	CcSEcCtD
Alprazolam—Infestation—Methotrexate—esophageal cancer	0.00159	0.0026	CcSEcCtD
Alprazolam—Infestation NOS—Methotrexate—esophageal cancer	0.00159	0.0026	CcSEcCtD
Alprazolam—Drowsiness—Methotrexate—esophageal cancer	0.00159	0.0026	CcSEcCtD
Alprazolam—Depression—Methotrexate—esophageal cancer	0.00158	0.0026	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00157	0.00258	CcSEcCtD
Alprazolam—Vision blurred—Capecitabine—esophageal cancer	0.00157	0.00258	CcSEcCtD
Alprazolam—Tremor—Capecitabine—esophageal cancer	0.00156	0.00256	CcSEcCtD
Alprazolam—Ill-defined disorder—Capecitabine—esophageal cancer	0.00155	0.00254	CcSEcCtD
Alprazolam—Sweating—Methotrexate—esophageal cancer	0.00152	0.0025	CcSEcCtD
Alprazolam—Feeling abnormal—Cisplatin—esophageal cancer	0.00152	0.00249	CcSEcCtD
Alprazolam—Malaise—Capecitabine—esophageal cancer	0.0015	0.00247	CcSEcCtD
Alprazolam—Hepatobiliary disease—Methotrexate—esophageal cancer	0.0015	0.00246	CcSEcCtD
Alprazolam—Epistaxis—Methotrexate—esophageal cancer	0.0015	0.00246	CcSEcCtD
Alprazolam—Vertigo—Capecitabine—esophageal cancer	0.0015	0.00246	CcSEcCtD
Alprazolam—Syncope—Capecitabine—esophageal cancer	0.00149	0.00245	CcSEcCtD
Alprazolam—Palpitations—Capecitabine—esophageal cancer	0.00147	0.00242	CcSEcCtD
Alprazolam—Loss of consciousness—Capecitabine—esophageal cancer	0.00147	0.0024	CcSEcCtD
Alprazolam—Body temperature increased—Cisplatin—esophageal cancer	0.00146	0.00239	CcSEcCtD
Alprazolam—Hepatitis—Methotrexate—esophageal cancer	0.00143	0.00234	CcSEcCtD
Alprazolam—Myalgia—Capecitabine—esophageal cancer	0.00142	0.00233	CcSEcCtD
Alprazolam—Chest pain—Capecitabine—esophageal cancer	0.00142	0.00233	CcSEcCtD
Alprazolam—Arthralgia—Capecitabine—esophageal cancer	0.00142	0.00233	CcSEcCtD
Alprazolam—Anxiety—Capecitabine—esophageal cancer	0.00141	0.00232	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00141	0.00231	CcSEcCtD
Alprazolam—Urinary tract disorder—Methotrexate—esophageal cancer	0.00141	0.00231	CcSEcCtD
Alprazolam—Discomfort—Capecitabine—esophageal cancer	0.0014	0.0023	CcSEcCtD
Alprazolam—Urethral disorder—Methotrexate—esophageal cancer	0.0014	0.00229	CcSEcCtD
Alprazolam—Flurazepam—CYP2A6—esophageal cancer	0.00139	0.182	CrCbGaD
Alprazolam—Dry mouth—Capecitabine—esophageal cancer	0.00139	0.00228	CcSEcCtD
Alprazolam—Confusional state—Capecitabine—esophageal cancer	0.00137	0.00225	CcSEcCtD
Alprazolam—Oedema—Capecitabine—esophageal cancer	0.00136	0.00223	CcSEcCtD
Alprazolam—Hypersensitivity—Cisplatin—esophageal cancer	0.00136	0.00223	CcSEcCtD
Alprazolam—Infection—Capecitabine—esophageal cancer	0.00135	0.00222	CcSEcCtD
Alprazolam—Erythema multiforme—Methotrexate—esophageal cancer	0.00135	0.00221	CcSEcCtD
Alprazolam—Shock—Capecitabine—esophageal cancer	0.00134	0.0022	CcSEcCtD
Alprazolam—Nervous system disorder—Capecitabine—esophageal cancer	0.00133	0.00219	CcSEcCtD
Alprazolam—Eye disorder—Methotrexate—esophageal cancer	0.00133	0.00218	CcSEcCtD
Alprazolam—Tinnitus—Methotrexate—esophageal cancer	0.00133	0.00218	CcSEcCtD
Alprazolam—Tachycardia—Capecitabine—esophageal cancer	0.00133	0.00218	CcSEcCtD
Alprazolam—Asthenia—Cisplatin—esophageal cancer	0.00132	0.00217	CcSEcCtD
Alprazolam—Cardiac disorder—Methotrexate—esophageal cancer	0.00132	0.00217	CcSEcCtD
Alprazolam—Skin disorder—Capecitabine—esophageal cancer	0.00132	0.00217	CcSEcCtD
Alprazolam—Hyperhidrosis—Capecitabine—esophageal cancer	0.00132	0.00216	CcSEcCtD
Alprazolam—Anorexia—Capecitabine—esophageal cancer	0.0013	0.00213	CcSEcCtD
Alprazolam—Angiopathy—Methotrexate—esophageal cancer	0.00129	0.00212	CcSEcCtD
Alprazolam—Mediastinal disorder—Methotrexate—esophageal cancer	0.00128	0.00211	CcSEcCtD
Alprazolam—Chills—Methotrexate—esophageal cancer	0.00128	0.0021	CcSEcCtD
Alprazolam—Hypotension—Capecitabine—esophageal cancer	0.00127	0.00209	CcSEcCtD
Alprazolam—Diarrhoea—Cisplatin—esophageal cancer	0.00126	0.00207	CcSEcCtD
Alprazolam—Mental disorder—Methotrexate—esophageal cancer	0.00125	0.00205	CcSEcCtD
Alprazolam—Malnutrition—Methotrexate—esophageal cancer	0.00124	0.00204	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00124	0.00203	CcSEcCtD
Alprazolam—Insomnia—Capecitabine—esophageal cancer	0.00123	0.00202	CcSEcCtD
Alprazolam—Paraesthesia—Capecitabine—esophageal cancer	0.00122	0.002	CcSEcCtD
Alprazolam—Dyspnoea—Capecitabine—esophageal cancer	0.00121	0.00199	CcSEcCtD
Alprazolam—Back pain—Methotrexate—esophageal cancer	0.0012	0.00197	CcSEcCtD
Alprazolam—Dyspepsia—Capecitabine—esophageal cancer	0.0012	0.00196	CcSEcCtD
Alprazolam—Decreased appetite—Capecitabine—esophageal cancer	0.00118	0.00194	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00117	0.00193	CcSEcCtD
Alprazolam—Vomiting—Cisplatin—esophageal cancer	0.00117	0.00192	CcSEcCtD
Alprazolam—Fatigue—Capecitabine—esophageal cancer	0.00117	0.00192	CcSEcCtD
Alprazolam—Vision blurred—Methotrexate—esophageal cancer	0.00117	0.00192	CcSEcCtD
Alprazolam—Rash—Cisplatin—esophageal cancer	0.00116	0.00191	CcSEcCtD
Alprazolam—Constipation—Capecitabine—esophageal cancer	0.00116	0.00191	CcSEcCtD
Alprazolam—Dermatitis—Cisplatin—esophageal cancer	0.00116	0.00191	CcSEcCtD
Alprazolam—Ill-defined disorder—Methotrexate—esophageal cancer	0.00115	0.00189	CcSEcCtD
Alprazolam—Feeling abnormal—Capecitabine—esophageal cancer	0.00112	0.00184	CcSEcCtD
Alprazolam—Malaise—Methotrexate—esophageal cancer	0.00112	0.00184	CcSEcCtD
Alprazolam—Vertigo—Methotrexate—esophageal cancer	0.00111	0.00183	CcSEcCtD
Alprazolam—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00111	0.00182	CcSEcCtD
Alprazolam—Nausea—Cisplatin—esophageal cancer	0.0011	0.0018	CcSEcCtD
Alprazolam—Urticaria—Capecitabine—esophageal cancer	0.00108	0.00177	CcSEcCtD
Alprazolam—Abdominal pain—Capecitabine—esophageal cancer	0.00108	0.00176	CcSEcCtD
Alprazolam—Body temperature increased—Capecitabine—esophageal cancer	0.00108	0.00176	CcSEcCtD
Alprazolam—Convulsion—Methotrexate—esophageal cancer	0.00108	0.00176	CcSEcCtD
Alprazolam—Arthralgia—Methotrexate—esophageal cancer	0.00106	0.00173	CcSEcCtD
Alprazolam—Chest pain—Methotrexate—esophageal cancer	0.00106	0.00173	CcSEcCtD
Alprazolam—Myalgia—Methotrexate—esophageal cancer	0.00106	0.00173	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00105	0.00172	CcSEcCtD
Alprazolam—Discomfort—Methotrexate—esophageal cancer	0.00104	0.00171	CcSEcCtD
Alprazolam—Confusional state—Methotrexate—esophageal cancer	0.00102	0.00167	CcSEcCtD
Alprazolam—Infection—Methotrexate—esophageal cancer	0.00101	0.00165	CcSEcCtD
Alprazolam—Hypersensitivity—Capecitabine—esophageal cancer	0.001	0.00164	CcSEcCtD
Alprazolam—Ketazolam—ABCB1—esophageal cancer	0.000998	0.13	CrCbGaD
Alprazolam—Nervous system disorder—Methotrexate—esophageal cancer	0.000993	0.00163	CcSEcCtD
Alprazolam—Skin disorder—Methotrexate—esophageal cancer	0.000984	0.00161	CcSEcCtD
Alprazolam—Hyperhidrosis—Methotrexate—esophageal cancer	0.000979	0.00161	CcSEcCtD
Alprazolam—Asthenia—Capecitabine—esophageal cancer	0.000976	0.0016	CcSEcCtD
Alprazolam—Anorexia—Methotrexate—esophageal cancer	0.000965	0.00158	CcSEcCtD
Alprazolam—Pruritus—Capecitabine—esophageal cancer	0.000962	0.00158	CcSEcCtD
Alprazolam—Hypotension—Methotrexate—esophageal cancer	0.000946	0.00155	CcSEcCtD
Alprazolam—Diarrhoea—Capecitabine—esophageal cancer	0.000931	0.00153	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000923	0.00151	CcSEcCtD
Alprazolam—Insomnia—Methotrexate—esophageal cancer	0.000916	0.0015	CcSEcCtD
Alprazolam—Paraesthesia—Methotrexate—esophageal cancer	0.000909	0.00149	CcSEcCtD
Alprazolam—Dyspnoea—Methotrexate—esophageal cancer	0.000903	0.00148	CcSEcCtD
Alprazolam—Somnolence—Methotrexate—esophageal cancer	0.0009	0.00148	CcSEcCtD
Alprazolam—Dizziness—Capecitabine—esophageal cancer	0.0009	0.00148	CcSEcCtD
Alprazolam—Dyspepsia—Methotrexate—esophageal cancer	0.000891	0.00146	CcSEcCtD
Alprazolam—Decreased appetite—Methotrexate—esophageal cancer	0.00088	0.00144	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000874	0.00143	CcSEcCtD
Alprazolam—Fatigue—Methotrexate—esophageal cancer	0.000873	0.00143	CcSEcCtD
Alprazolam—Vomiting—Capecitabine—esophageal cancer	0.000865	0.00142	CcSEcCtD
Alprazolam—Rash—Capecitabine—esophageal cancer	0.000858	0.00141	CcSEcCtD
Alprazolam—Dermatitis—Capecitabine—esophageal cancer	0.000857	0.00141	CcSEcCtD
Alprazolam—Headache—Capecitabine—esophageal cancer	0.000852	0.0014	CcSEcCtD
Alprazolam—Diazepam—PTGS1—esophageal cancer	0.000848	0.11	CrCbGaD
Alprazolam—Feeling abnormal—Methotrexate—esophageal cancer	0.000835	0.00137	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000828	0.00136	CcSEcCtD
Alprazolam—Nausea—Capecitabine—esophageal cancer	0.000808	0.00133	CcSEcCtD
Alprazolam—Urticaria—Methotrexate—esophageal cancer	0.000805	0.00132	CcSEcCtD
Alprazolam—Body temperature increased—Methotrexate—esophageal cancer	0.000801	0.00131	CcSEcCtD
Alprazolam—Abdominal pain—Methotrexate—esophageal cancer	0.000801	0.00131	CcSEcCtD
Alprazolam—Hypersensitivity—Methotrexate—esophageal cancer	0.000746	0.00122	CcSEcCtD
Alprazolam—Asthenia—Methotrexate—esophageal cancer	0.000727	0.00119	CcSEcCtD
Alprazolam—Pruritus—Methotrexate—esophageal cancer	0.000716	0.00118	CcSEcCtD
Alprazolam—Clobazam—ABCB1—esophageal cancer	0.000706	0.092	CrCbGaD
Alprazolam—Diarrhoea—Methotrexate—esophageal cancer	0.000693	0.00114	CcSEcCtD
Alprazolam—Dizziness—Methotrexate—esophageal cancer	0.00067	0.0011	CcSEcCtD
Alprazolam—Vomiting—Methotrexate—esophageal cancer	0.000644	0.00106	CcSEcCtD
Alprazolam—CYP3A7—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000642	0.00168	CbGpPWpGaD
Alprazolam—Rash—Methotrexate—esophageal cancer	0.000639	0.00105	CcSEcCtD
Alprazolam—Dermatitis—Methotrexate—esophageal cancer	0.000638	0.00105	CcSEcCtD
Alprazolam—Headache—Methotrexate—esophageal cancer	0.000634	0.00104	CcSEcCtD
Alprazolam—GABRA1—Neuronal System—ALDH2—esophageal cancer	0.000634	0.00166	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000632	0.00165	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000632	0.00165	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000632	0.00165	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00063	0.00165	CbGpPWpGaD
Alprazolam—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000628	0.00164	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000624	0.00163	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000622	0.00163	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.000621	0.00162	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—ALDH2—esophageal cancer	0.000621	0.00162	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000621	0.00162	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000621	0.00162	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000617	0.00161	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000617	0.00161	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—CYP19A1—esophageal cancer	0.000612	0.0016	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00061	0.0016	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000606	0.00158	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000606	0.00158	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000604	0.00158	CbGpPWpGaD
Alprazolam—Nausea—Methotrexate—esophageal cancer	0.000602	0.000987	CcSEcCtD
Alprazolam—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000591	0.00154	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GSTT1—esophageal cancer	0.000591	0.00154	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000587	0.00153	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP2A6—esophageal cancer	0.000584	0.00153	CbGpPWpGaD
Alprazolam—Nitrazepam—ABCB1—esophageal cancer	0.000583	0.076	CrCbGaD
Alprazolam—GABRA1—Orphan transporters—CREBBP—esophageal cancer	0.000583	0.00152	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000579	0.00151	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000578	0.00151	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00057	0.00149	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—PTGS1—esophageal cancer	0.000553	0.00145	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000552	0.00144	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000543	0.00142	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000537	0.0014	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.00053	0.00138	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000529	0.00138	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000529	0.00138	CbGpPWpGaD
Alprazolam—Flurazepam—ABCB1—esophageal cancer	0.000519	0.0676	CrCbGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000516	0.00135	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000511	0.00134	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000508	0.00133	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000502	0.00131	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000501	0.00131	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000487	0.00127	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000484	0.00127	CbGpPWpGaD
Alprazolam—Midazolam—ABCB1—esophageal cancer	0.000481	0.0627	CrCbGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000479	0.00125	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000478	0.00125	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000471	0.00123	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP1B1—esophageal cancer	0.000471	0.00123	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00047	0.00123	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000467	0.00122	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000467	0.00122	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000464	0.00121	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000459	0.0012	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000455	0.00119	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP19A1—esophageal cancer	0.000442	0.00116	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000442	0.00116	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000438	0.00114	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000436	0.00114	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000434	0.00114	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000427	0.00112	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000424	0.00111	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000421	0.0011	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000416	0.00109	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000416	0.00109	CbGpPWpGaD
Alprazolam—Diazepam—ABCB1—esophageal cancer	0.000412	0.0537	CrCbGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000412	0.00108	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000412	0.00108	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.00041	0.00107	CbGpPWpGaD
Alprazolam—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000402	0.00105	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000401	0.00105	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.00039	0.00102	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000387	0.00101	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000381	0.000995	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000376	0.000982	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000364	0.000951	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000354	0.000925	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000349	0.000913	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000332	0.000867	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—BLVRB—esophageal cancer	0.000329	0.000859	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC52A3—esophageal cancer	0.000329	0.000859	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000327	0.000855	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00032	0.000836	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000312	0.000815	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000308	0.000804	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000289	0.000754	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000287	0.00075	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC10A2—esophageal cancer	0.00028	0.000731	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CA1—esophageal cancer	0.00028	0.000731	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000277	0.000725	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000275	0.000718	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000271	0.000709	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00027	0.000704	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000266	0.000696	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000265	0.000692	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00026	0.00068	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000259	0.000676	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000258	0.000675	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000257	0.000672	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CA2—esophageal cancer	0.000256	0.000668	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000254	0.000664	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000254	0.000663	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00025	0.000652	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000248	0.000648	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000244	0.000636	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ADH7—esophageal cancer	0.000238	0.000621	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.000238	0.000621	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000238	0.000621	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000238	0.000621	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000222	0.00058	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000219	0.000572	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000216	0.000565	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000216	0.000564	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000213	0.000556	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.000209	0.000545	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000206	0.000538	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000203	0.00053	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CA1—esophageal cancer	0.000202	0.000528	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000202	0.000528	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TYMP—esophageal cancer	0.000199	0.000521	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000194	0.000507	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.000189	0.000494	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000189	0.000493	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CA2—esophageal cancer	0.000185	0.000483	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTO1—esophageal cancer	0.00018	0.000471	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TPI1—esophageal cancer	0.00018	0.000471	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000178	0.000465	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000173	0.000452	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALDOB—esophageal cancer	0.000173	0.000451	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000172	0.000449	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000172	0.000449	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00017	0.000444	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000168	0.000438	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000168	0.000438	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000167	0.000436	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GAPDH—esophageal cancer	0.000166	0.000435	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000166	0.000433	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CRABP1—esophageal cancer	0.000165	0.000431	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000163	0.000425	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GNG7—esophageal cancer	0.000157	0.00041	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000151	0.000394	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00015	0.000392	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.000147	0.000384	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000144	0.000376	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CA1—esophageal cancer	0.000143	0.000372	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000143	0.000372	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000142	0.000372	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.00014	0.000366	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.00014	0.000365	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.000138	0.000361	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000137	0.000357	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000131	0.000342	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000131	0.000342	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CA2—esophageal cancer	0.00013	0.000341	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TPI1—esophageal cancer	0.00013	0.00034	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.00013	0.00034	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000129	0.000337	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000129	0.000337	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000127	0.000333	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000125	0.000326	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000121	0.000317	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000121	0.000317	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.00012	0.000314	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00012	0.000313	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000119	0.000311	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000113	0.000296	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1B1—esophageal cancer	0.000111	0.000291	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000111	0.000289	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000111	0.000289	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000106	0.000278	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000106	0.000278	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP19A1—esophageal cancer	0.000105	0.000274	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000102	0.000265	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.000101	0.000264	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2A6—esophageal cancer	9.98e-05	0.000261	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP26A1—esophageal cancer	9.88e-05	0.000258	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALOX15—esophageal cancer	9.63e-05	0.000252	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMOX1—esophageal cancer	9.55e-05	0.00025	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ENO1—esophageal cancer	9.46e-05	0.000247	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS1—esophageal cancer	9.46e-05	0.000247	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CA1—esophageal cancer	9.4e-05	0.000246	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.4e-05	0.000246	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PSME2—esophageal cancer	9.33e-05	0.000244	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PSME1—esophageal cancer	9.33e-05	0.000244	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TPI1—esophageal cancer	9.18e-05	0.00024	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.18e-05	0.00024	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCB1—esophageal cancer	9.17e-05	0.00024	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALDOB—esophageal cancer	8.8e-05	0.00023	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CA2—esophageal cancer	8.6e-05	0.000225	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GAPDH—esophageal cancer	8.47e-05	0.000221	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CRABP1—esophageal cancer	8.4e-05	0.000219	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.05e-05	0.00021	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.99e-05	0.000209	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ADH7—esophageal cancer	7.99e-05	0.000209	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GNG7—esophageal cancer	7.99e-05	0.000209	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP19A1—esophageal cancer	7.57e-05	0.000198	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALDH2—esophageal cancer	7.49e-05	0.000196	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.12e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.04e-05	0.000184	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.01e-05	0.000183	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.01e-05	0.000183	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMOX1—esophageal cancer	6.9e-05	0.00018	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TYMP—esophageal cancer	6.7e-05	0.000175	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ENO1—esophageal cancer	6.67e-05	0.000174	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS1—esophageal cancer	6.67e-05	0.000174	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCB1—esophageal cancer	6.63e-05	0.000173	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PSME1—esophageal cancer	6.57e-05	0.000172	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PSME2—esophageal cancer	6.57e-05	0.000172	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.51e-05	0.00017	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.35e-05	0.000166	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.13e-05	0.00016	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.06e-05	0.000158	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TPI1—esophageal cancer	6.06e-05	0.000158	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.81e-05	0.000152	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.74e-05	0.00015	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1B1—esophageal cancer	5.67e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.59e-05	0.000146	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.54e-05	0.000145	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NOS3—esophageal cancer	5.49e-05	0.000143	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.33e-05	0.000139	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GNG7—esophageal cancer	5.27e-05	0.000138	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.02e-05	0.000131	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.94e-05	0.000129	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMOX1—esophageal cancer	4.87e-05	0.000127	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.77e-05	0.000125	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.7e-05	0.000123	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCB1—esophageal cancer	4.67e-05	0.000122	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.64e-05	0.000121	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.43e-05	0.000116	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ENO1—esophageal cancer	4.4e-05	0.000115	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.4e-05	0.000115	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PSME1—esophageal cancer	4.34e-05	0.000113	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PSME2—esophageal cancer	4.34e-05	0.000113	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—EP300—esophageal cancer	4.17e-05	0.000109	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NOS3—esophageal cancer	3.97e-05	0.000104	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.74e-05	9.78e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.63e-05	9.48e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.53e-05	9.23e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.52e-05	9.19e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.21e-05	8.39e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.12e-05	8.16e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.09e-05	8.07e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.08e-05	8.05e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—EP300—esophageal cancer	3.02e-05	7.88e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NOS3—esophageal cancer	2.8e-05	7.31e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.56e-05	6.68e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.23e-05	5.83e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—EP300—esophageal cancer	2.13e-05	5.56e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.06e-05	5.38e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NOS3—esophageal cancer	1.84e-05	4.82e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.69e-05	4.41e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.57e-05	4.11e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—EP300—esophageal cancer	1.4e-05	3.66e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.04e-05	2.71e-05	CbGpPWpGaD
